The Union Budget 2024 has limited provisions impacting the pharma and healthcare sectors. It has provided relief to cancer patients by fully exempting three more medicines from custom duties. These drugs are Trastuzumab Deruxtecan, Osimertinib and Durvalumab - drugs manufactured and sold by AstraZeneca. The stock of Astrazeneca India closed over 13% today.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/EwMq4Zf
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment